Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Fake Wall, Byte me Shorters

<< Previous

Bullboard Posts

Next >>

Post by Dude51on Mar 09, 2021 8:34am

148 Views

Post# 32750702

Fake Wall, Byte me Shorters

Hey folks pay no attention to the fake wall. The shorters are always trying to make it look like everyone is selling and hardly anyone wants to buy. Look at other stocks do you see a big wall at the sell. Most stocks no. Its just noise from the shorters, ignore.

<< Previous

Bullboard Posts

Next >>

Record Q3: Equinox Gold achieves commercial production at Greenstone Mine